Literature DB >> 8642679

Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

L J Diehl1, C K Mathiason-Dubard, L L O'Neil, E A Hoover.   

Abstract

Viral RNA load has been shown to indicate disease stage and predict the rapidity of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected individuals. We had previously demonstrated that feline immunodeficiency virus (FIV) RNA levels in plasma correlate with disease stage in infected cats. Here we expand upon those observations by demonstrating that plasma virus load is 1 to 2 logs higher in cats with rapidly progressive FIV disease than in long-term survivors. Differences in plasma FIV RNA levels are evident by 1 to 2 weeks after infection and are consistent throughout infection. We also evaluated humoral immune responses in FIV-infected cats for correlation with survival times. Total anti-FIV antibody titers did not differ between cats with rapidly progressive FIV disease and long-term survivors. These findings indicate that virus replication plays an important role in FIV disease progression, as it does in HIV-1 disease progression. The parallels in virus loads and disease progressions between HIV-1 and FIV support the idea that the accelerated disease model is well suited for the study of therapeutic agents directed at reducing lentiviral replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642679      PMCID: PMC190095     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology.

Authors:  M W Cloyd; W S Lynn
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

2.  Clinical staging of feline immunodeficiency virus infection.

Authors:  T Ishida; I Tomoda
Journal:  Nihon Juigaku Zasshi       Date:  1990-06

Review 3.  Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats.

Authors:  E E Sparger; P A Luciw; J H Elder; J K Yamamoto; L J Lowenstine; N C Pedersen
Journal:  AIDS       Date:  1989       Impact factor: 4.177

Review 4.  Early events in the immunopathogenesis of feline retrovirus infections.

Authors:  M B Tompkins; P D Nelson; R V English; C Novotney
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

5.  Hematologic manifestations of feline immunodeficiency virus infection.

Authors:  G H Shelton; M L Linenberger; C K Grant; J L Abkowitz
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

6.  Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates.

Authors:  M W Cloyd; B E Moore
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

7.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.

Authors:  M Piatak; K C Luk; B Williams; J D Lifson
Journal:  Biotechniques       Date:  1993-01       Impact factor: 1.993

9.  Serological responses of cats to feline immunodeficiency virus.

Authors:  M J Hosie; O Jarrett
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

10.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

View more
  12 in total

1.  Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.

Authors:  Hong Na; Willem Huisman; Kristofor K Ellestad; Tom R Phillips; Christopher Power
Journal:  Virology       Date:  2010-06-08       Impact factor: 3.616

2.  In vivo monocyte tropism of pathogenic feline immunodeficiency viruses.

Authors:  S W Dow; C K Mathiason; E A Hoover
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus.

Authors:  Yuko Goto; Yoshiaki Nishimura; Kenji Baba; Takuya Mizuno; Yasuyuki Endo; Kenichi Masuda; Koichi Ohno; Hajime Tsujimoto
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 4.  The molecular biology and evolution of feline immunodeficiency viruses of cougars.

Authors:  Mary Poss; Howard Ross; Allen Rodrigo; Julie Terwee; Sue Vandewoude; Roman Biek
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 5.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

6.  Immunohistochemical localization of feline immunodeficiency virus using native species antibodies.

Authors:  Arlin B Rogers; Candace K Mathiason; Edward A Hoover
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

7.  Gamma interferon/interleukin 10 balance in tissue lymphocytes correlates with down modulation of mucosal feline immunodeficiency virus infection.

Authors:  Paul R Avery; Edward A Hoover
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3.

Authors:  Sohela de Rozières; Christina H Swan; Dennis A Sheeter; Karen J Clingerman; Ying-Chuan Lin; Salvador Huitron-Resendiz; Steven Henriksen; Bruce E Torbett; John H Elder
Journal:  Retrovirology       Date:  2004-11-19       Impact factor: 4.602

Review 9.  Feline immunodeficiency virus latency.

Authors:  Samantha J McDonnel; Ellen E Sparger; Brian G Murphy
Journal:  Retrovirology       Date:  2013-07-06       Impact factor: 4.602

10.  Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.

Authors:  C D Eckstrand; C Hillman; A L Smith; E E Sparger; B G Murphy
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.